Jim Cramer recently highlighted a promising start to earnings season, pondering whether the two-year-old bull market can continue its upward trajectory during an episode of Mad Money. To address ...

CNBC’s Jim Cramer previews key earnings reports and investor days that could trigger Wall Street action for the week of ...

CNBC’s Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while ...

We recently compiled a list of the Jim Cramer’s Best Performers List: Top 10 Stocks. In this article, we are going to take a ...

The market likes Donald J. Trump, and it loves a peaceful transition to the next president. We got both, and we had a monster ...

We recently compiled a list of the Jim Cramer’s Best Performers List: Top 10 Stocks. In this article, we are going to take a ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Coterra ... Bill Chappell maintained e.l.f. Beauty with a Buy and lowered the price target from $210 to $130.

SoFi Technologies, Inc. is good, Jim Cramer said. It reported third-quarter adjusted sales of $689.445 million, according to ...

"I'm more inclined to buy Pfizer, Pfizer offloads these low multiples, these low a low margin drugs and Pfizer's down. That's wrong," said Cramer. But, it's not the only drug stock that he's watching.

“Mad Money” host Jim Cramer has expressed interest ... What Happened: Cramer wants to “buy more" of Disney, should the stock dip below the $90 mark, CNBC reported on Thursday.

CNBC’s Jim Cramer suggested that if Trump’s new tax plans are similar to those he implemented in 2016, wealthy people will ...

Jim Cramer discusses Boeing, Best Buy, Palo Alto, the market impact of the full approval of the Pfizer vaccine and much more in Tuesday's video interview with TheStreet Live. Stocks opened higher ...